These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38293085)

  • 41. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy.
    Su T; Cheng F; Qi J; Zhang Y; Zhou S; Mei L; Fu S; Zhang F; Lin S; Zhu G
    Adv Sci (Weinh); 2022 Aug; 9(23):e2201895. PubMed ID: 35712773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition.
    Erlmeier F; Klümper N; Landgraf L; Strissel PL; Strick R; Sikic D; Taubert H; Wach S; Geppert CI; Bahlinger V; Breyer J; Ritter M; Bolenz C; Roghmann F; Erben P; Schwamborn K; Wirtz RM; Horn T; Wullich B; Hölzel M; Hartmann A; Gschwend JE; Weichert W; Eckstein M
    Eur Urol; 2023 Feb; 83(2):133-142. PubMed ID: 36372626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma.
    Bolte LA; Lee KA; Björk JR; Leeming ER; Campmans-Kuijpers MJE; de Haan JJ; Vila AV; Maltez-Thomas A; Segata N; Board R; Harries M; Lorigan P; de Vries EGE; Nathan P; Fehrmann R; Bataille V; Spector TD; Hospers GAP; Weersma RK
    JAMA Oncol; 2023 May; 9(5):705-709. PubMed ID: 36795408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade.
    Sun B; Xun Z; Zhang N; Liu K; Chen X; Zhao H
    Cancer Cell Int; 2023 Dec; 23(1):313. PubMed ID: 38066642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center.
    Rosenbaum E; Antonescu CR; Smith S; Bradic M; Kashani D; Richards AL; Donoghue M; Kelly CM; Nacev B; Chan JE; Chi P; Dickson MA; Keohan ML; Gounder MM; Movva S; Avutu V; Thornton K; Zehir A; Bowman AS; Singer S; Tap W; D'Angelo S
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35365586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation.
    Zhang B; Li J; Hua Q; Wang H; Xu G; Chen J; Zhu Y; Li R; Liang Q; Wang L; Jin M; Tang J; Lin Z; Zhao L; Zhang D; Yu D; Ren J; Zhang T
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36596591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer.
    Negrao MV; Lam VK; Reuben A; Rubin ML; Landry LL; Roarty EB; Rinsurongkawong W; Lewis J; Roth JA; Swisher SG; Gibbons DL; Wistuba II; Papadimitrakopoulou V; Glisson BS; Blumenschein GR; Lee JJ; Heymach JV; Zhang J
    J Thorac Oncol; 2019 Jun; 14(6):1021-1031. PubMed ID: 30780001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
    Scott SC; Shao XM; Niknafs N; Balan A; Pereira G; Marrone KA; Lam VK; Murray JC; Feliciano JL; Levy BP; Ettinger DS; Hann CL; Brahmer JR; Forde PM; Karchin R; Naidoo J; Anagnostou V
    Front Oncol; 2022; 12():945798. PubMed ID: 35992816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
    Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer.
    Piening A; Ebert E; Khojandi N; Alspach E; Teague RM
    Front Immunol; 2022; 13():1022732. PubMed ID: 36582225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules.
    Wang W; Dong D; Chen L; Wang H; Bi B; Liu T
    Front Genet; 2022; 13():893380. PubMed ID: 35937997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.
    Zhu S; Ma AH; Zhu Z; Adib E; Rao T; Li N; Ni K; Chittepu VCSR; Prabhala R; Garisto Risco J; Kwiatkowski D; Mouw K; Sonpavde G; Cheng F; Pan CX
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34725212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.
    van der Westhuizen A; Lyle M; Graves MC; Zhu X; Wong JWH; Cornall K; Ren S; Pugliese L; Levy R; Majid A; Vilain RE; Bowden NA
    Cancer Res Commun; 2022 Aug; 2(8):814-826. PubMed ID: 36923309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.
    Burrack AL; Spartz EJ; Raynor JF; Wang I; Olson M; Stromnes IM
    Cell Rep; 2019 Aug; 28(8):2140-2155.e6. PubMed ID: 31433988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing.
    Hiatt JB; Sandborg H; Garrison SM; Arnold HU; Liao SY; Norton JP; Friesen TJ; Wu F; Sutherland KD; Rienhoff HY; Martins R; Houghton AM; Srivastava S; MacPherson D
    Clin Cancer Res; 2022 Oct; 28(20):4551-4564. PubMed ID: 35920742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
    Sun S; Xu L; Zhang X; Pang L; Long Z; Deng C; Zhu J; Zhou S; Wan L; Pang B; Xiao Y
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.
    Abbott CW; Boyle SM; Pyke RM; McDaniel LD; Levy E; Navarro FCP; Mellacheruvu D; Zhang SV; Tan M; Santiago R; Rusan ZM; Milani P; Bartha G; Harris J; McClory R; Snyder MP; Jang S; Chen R
    Clin Cancer Res; 2021 Aug; 27(15):4265-4276. PubMed ID: 34341053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
    Chen IX; Newcomer K; Pauken KE; Juneja VR; Naxerova K; Wu MW; Pinter M; Sen DR; Singer M; Sharpe AH; Jain RK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23684-23694. PubMed ID: 32907939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
    Shen R; Postow MA; Adamow M; Arora A; Hannum M; Maher C; Wong P; Curran MA; Hollmann TJ; Jia L; Al-Ahmadie H; Keegan N; Funt SA; Iyer G; Rosenberg JE; Bajorin DF; Chapman PB; Shoushtari AN; Betof AS; Momtaz P; Merghoub T; Wolchok JD; Panageas KS; Callahan MK
    Sci Transl Med; 2021 Aug; 13(608):. PubMed ID: 34433638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.